Inventor · San Francisco, CA, US

David Liu

42Patents
8h-index
22Co-inventors
67Inventor score

Filing activity: Dec 4, 2012 → Jun 22, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US8986972B2 Nucleic acid encoding DLL3 antibodies Physics 16 Active
US9089615B2 Anti-DLL3 antibodies Physics 16 Active
US9089617B2 Anti-DLL3 antibody drug conjugates Physics 9 Active
US9155803B1 Anti-DLL3 antibody drug conjugates and methods of use Physics 8 Active
US9107961B2 Anti-DLL3 antibody drug conjugates for treating cancer Physics 8 Active
US9133271B1 Anti-DLL3 antibody drug conjugates and methods of use Physics 8 Active
US9334318B1 Multivalent DLL3 antibodies Physics 8 Active
US9353182B2 Anti-DLL3 antibodies Physics 8 Active
US10035853B2 Site-specific antibody conjugation methods and compositions Chemistry; Metallurgy 8 Active
US9090683B2 Methods of detection, diagnosis, and monitoring using anti-DLL3 antibodies Physics 8 Active
US9089616B2 Anti-DLL3 antibody drug conjugates and methods of use Physics 8 Active
US9352051B1 Kits containing DLL3 antibody drug conjugates Physics 8 Active
US9358304B1 Methods of making DLL3 antibody drug conjugates Physics 8 Active
US9770518B1 Anti-DLL3 antibody drug conjugates Physics 7 Active
US9931421B2 Methods of delivering DLL3 antibody drug conjugates Physics 7 Active
US9931420B2 Methods of making DLL3 antibody drug conjugates Physics 7 Active
US9861708B2 Kits containing DLL3 antibody drug conjugates Physics 7 Active
US9775916B1 Anti-DLL3 antibody drug conjugates for treating cancer Physics 7 Active
US9480757B2 Anti-DLL3 antibody drug conjugates Physics 7 Active
US9878053B2 Methods of delivering DLL3 antibody drug conjugates Physics 7 Active
US9867887B1 Anti-DLL3 antibody drug conjugates Physics 7 Active
US9937268B2 Anti-DLL3 antibody drug conjugates and methods of use Physics 7 Active
US9764042B1 Methods of making DLL3 antibody drug conjugates Physics 7 Active
US9486537B2 Anti-DLL3 antibody drug conjugates Physics 7 Active
US9855343B2 Anti-DLL3 antibody drug conjugates Physics 7 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.